Abi-Dargham, A, Mawlawi, O, Lombardo, I, Gil, R, Martinez, D, Huang, Y, Hwang, DR, Keilp, J, Kochan, L, Van Heertum, R, Gorman, JM, Laruelle, M (2002). Prefrontal dopamine D1 receptors and working memory in schizophrenia. Journal of Neuroscience 22, 3708–3719.
Adolphs, R (2008). Fear, faces, and the human amygdala. Current Opinion in Neurobiology 18, 166–172.
Adolphs, R (2010). What does the amygdala contribute to social cognition? Annals of the New York Academy of Sciences 1191, 42–61.
Akil, M, Kolachana, BS, Rothmond, DA, Hyde, TM, Weinberger, DR, Kleinman, JE (2003). Catechol-O-methyltransferase genotype and dopamine regulation in the human brain. Journal of Neuroscience 23, 2008–2013.
Alsobrook, JP 2nd, Zohar, AH, Leboyer, M, Chabane, N, Ebstein, RP, Pauls, DL (2002). Association between the COMT locus and obsessive-compulsive disorder in females but not males. American Journal of Medical Genetics 114, 116–120.
Badgaiyan, RD, Fischman, AJ, Alpert, NM (2009). Dopamine release during human emotional processing. Neuroimage 47, 2041–2045.
Bertolino, A, Breier, A, Callicott, JH, Adler, C, Mattay, VS, Shapiro, M, Frank, JA, Pickar, D, Weinberger, DR (2000). The relationship between dorsolateral prefrontal neuronal N-acetylaspartate and evoked release of striatal dopamine in schizophrenia. Neuropsychopharmacology 22, 125–132.
Bertolino, A, Caforio, G, Blasi, G, De Candia, M, Latorre, V, Petruzzella, V, Altamura, M, Nappi, G, Papa, S, Callicott, JH, Mattay, VS, Bellomo, A, Scarabino, T, Weinberger, DR, Nardini, M (2004). Interaction of COMT (Val108/158Met) genotype and olanzapine treatment on prefrontal cortical function in patients with schizophrenia. American Journal of Psychiatry 161, 1798–1805.
Bertolino, A, Knable, MB, Saunders, RC, Callicott, JH, Kolachana, B, Mattay, VS, Bachevalier, J, Frank, JA, Egan, M, Weinberger, DR (1999). The relationship between dorsolateral prefrontal N-acetylaspartate measures and striatal dopamine activity in schizophrenia. Biological Psychiatry 45, 660–667.
Bilder, RM, Volavka, J, Czobor, P, Malhotra, AK, Kennedy, JL, Ni, X, Goldman, RS, Hoptman, MJ, Sheitman, B, Lindenmayer, JP, Citrome, L, McEvoy, JP, Kunz, M, Chakos, M, Cooper, TB, Lieberman, JA (2002). Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia. Biological Psychiatry 52, 701–707.
Blasi, G, Hariri, AR, Alce, G, Taurisano, P, Sambataro, F, Das, S, Bertolino, A, Weinberger, DR, Mattay, VS (2009 a). Preferential amygdala reactivity to the negative assessment of neutral faces. Biological Psychiatry 66, 847–853.
Blasi, G, Lo Bianco, L, Taurisano, P, Gelao, B, Romano, R, Fazio, L, Papazacharias, A, Di Giorgio, A, Caforio, G, Rampino, A, Masellis, R, Papp, A, Ursini, G, Sinibaldi, L, Popolizio, T, Sadee, W, Bertolino, A (2009 b). Functional variation of the dopamine D2 receptor gene is associated with emotional control as well as brain activity and connectivity during emotion processing in humans. Journal of Neuroscience 29, 14812–14819.
Bolte, S, Poustka, F (2003). The recognition of facial affect in autistic and schizophrenic subjects and their first-degree relatives. Psychological Medicine 33, 907–915.
Boos, HB, Aleman, A, Cahn, W, Hulshoff Pol, H, Kahn, RS (2007). Brain volumes in relatives of patients with schizophrenia: a meta-analysis. Archives of General Psychiatry 64, 297–304.
Breiter, HC, Etcoff, NL, Whalen, PJ, Kennedy, WA, Rauch, SL, Buckner, RL, Strauss, MM, Hyman, SE, Rosen, BR (1996). Response and habituation of the human amygdala during visual processing of facial expression. Neuron 17, 875–887.
Brunelin, J, d'Amato, T, Van Os, J, Cochet, A, Suaud-Chagny, MF, Saoud, M (2008). Effects of acute metabolic stress on the dopaminergic and pituitary–adrenal axis activity in patients with schizophrenia, their unaffected siblings and controls. Schizophrenia Research 100, 206–211.
Brunelin, J, d'Amato, T, Van Os, J, Costes, N, Suaud Chagny, MF, Saoud, M (2010). Increased left striatal dopamine transmission in unaffected siblings of schizophrenia patients in response to acute metabolic stress. Psychiatry Research 181, 130–135.
Buchel, C, Morris, J, Dolan, RJ, Friston, KJ (1998). Brain systems mediating aversive conditioning: an event-related fMRI study. Neuron 20, 947–957.
Callicott, JH, Egan, MF, Mattay, VS, Bertolino, A, Bone, AD, Verchinksi, B, Weinberger, DR (2003 a). Abnormal fMRI response of the dorsolateral prefrontal cortex in cognitively intact siblings of patients with schizophrenia. American Journal of Psychiatry 160, 709–719.
Callicott, JH, Mattay, VS, Verchinski, BA, Marenco, S, Egan, MF, Weinberger, DR (2003 b). Complexity of prefrontal cortical dysfunction in schizophrenia: more than up or down. American Journal of Psychiatry 160, 2209–2215.
Carlsson, A (1988). The current status of the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 1, 179–186.
Chan, RC, Li, H, Cheung, EF, Gong, QY (2010). Impaired facial emotion perception in schizophrenia: a meta-analysis. Psychiatry Research 178, 381–390.
Chen, J, Lipska, BK, Halim, N, Ma, QD, Matsumoto, M, Melhem, S, Kolachana, BS, Hyde, TM, Herman, MM, Apud, J, Egan, MF, Kleinman, JE, Weinberger, DR (2004). Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. American Journal of Human Genetics 75, 807–821.
Chen, LS, Rice, TK, Thompson, PA, Barch, DM, Csernansky, JG (2009). Familial aggregation of clinical and neurocognitive features in sibling pairs with and without schizophrenia. Schizophrenia Research 111, 159–166.
Colzato, LS, Waszak, F, Nieuwenhuis, S, Posthuma, D, Hommel, B (2010). The flexible mind is associated with the catechol-O-methyltransferase (COMT) Val158Met polymorphism: evidence for a role of dopamine in the control of task-switching. Neuropsychologia 48, 2764–2768.
Das, P, Kemp, AH, Flynn, G, Harris, AW, Liddell, BJ, Whitford, TJ, Peduto, A, Gordon, E, Williams, LM (2007). Functional disconnections in the direct and indirect amygdala pathways for fear processing in schizophrenia. Schizophrenia Research 90, 284–294.
Delawalla, Z, Csernansky, JG, Barch, DM (2008). Prefrontal cortex function in nonpsychotic siblings of individuals with schizophrenia. Biological Psychiatry 63, 490–497.
Delgado, MR, Jou, RL, LeDoux, JE, Phelps, EA (2009). Avoiding negative outcomes: tracking the mechanisms of avoidance learning in humans during fear conditioning. Frontiers in Behavioral Neuroscience 3, 33.
Di Giorgio, A, Caforio, G, Blasi, G, Taurisano, P, Fazio, L, Romano, R, Ursini, G, Gelao, B, Bianco, LL, Papazacharias, A, Sinibaldi, L, Popolizio, T, Bellomo, A, Bertolino, A (2011). Catechol-O-methyltransferase Val158Met association with parahippocampal physiology during memory encoding in schizophrenia. Psychological Medicine 41, 1721–1731.
Dickinson, D, Elvevag, B (2009). Genes, cognition and brain through a COMT lens. Neuroscience 164, 72–87.
Domschke, K, Baune, BT, Havlik, L, Stuhrmann, A, Suslow, T, Kugel, H, Zwanzger, P, Grotegerd, D, Sehlmeyer, C, Arolt, V, Dannlowski, U (2012). Catechol-O-methyltransferase gene variation: impact on amygdala response to aversive stimuli. Neuroimage 60, 2222–2229.
Domschke, K, Freitag, CM, Kuhlenbäumer, G, Schirmacher, A, Sand, P, Nyhuis, P, Jacob, C, Fritze, J, Franke, P, Rietschel, M, Garritsen, HS, Fimmers, R, Nöthen, MM, Lesch, KP, Stögbauer, F, Deckert, J (2004). Association of the functional V158M catechol-O-methyl-transferase polymorphism with panic disorder in women. International Journal of Neuropsychopharmacology 7, 183–188.
Drabant, EM, Hariri, AR, Meyer-Lindenberg, A, Munoz, KE, Mattay, VS, Kolachana, BS, Egan, MF, Weinberger, DR (2006). Catechol O-methyltransferase val158met genotype and neural mechanisms related to affective arousal and regulation. Archives of General Psychiatry 63, 1396–1406.
Dreher, JC, Kohn, P, Kolachana, B, Weinberger, DR, Berman, KF (2009). Variation in dopamine genes influences responsivity of the human reward system. Proceedings of the National Academy of Sciences USA 106, 617–622.
Egan, MF, Goldberg, TE, Gscheidle, T, Weirich, M, Rawlings, R, Hyde, TM, Bigelow, L, Weinberger, DR (2001 a). Relative risk for cognitive impairments in siblings of patients with schizophrenia. Biological Psychiatry 50, 98–107.
Egan, MF, Goldberg, TE, Kolachana, BS, Callicott, JH, Mazzanti, CM, Straub, RE, Goldman, D, Weinberger, DR (2001 b). Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proceedings of the National Academy of Sciences USA 98, 6917–6922.
Enoch, MA, Xu, K, Ferro, E, Harris, CR, Goldman, D (2003). Genetic origins of anxiety in women: a role for a functional catechol-O-methyltransferase polymorphism. Psychiatric Genetics 13, 33–41.
Gogos, JA, Morgan, M, Luine, V, Santha, M, Ogawa, S, Pfaff, D, Karayiorgou, M (1998). Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proceedings of the National Academy of Sciences USA 95, 9991–9996.
Goudreau, JL, Maraganore, DM, Farrer, MJ, Lesnick, TG, Singleton, AB, Bower, JH, Hardy, JA, Rocca, WA (2002). Case–control study of dopamine transporter-1, monoamine oxidase-B, and catechol-O-methyl transferase polymorphisms in Parkinson's disease. Movement Disorders 17, 1305–1311.
Grace, AA (1991). Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience 41, 1–24.
Grace, AA (2000). Gating of information flow within the limbic system and the pathophysiology of schizophrenia. Brain Research. Brain Research Reviews 31, 330–341.
Grace, AA, Rosenkranz, JA (2002). Regulation of conditioned responses of basolateral amygdala neurons. Physiology and Behavior 77, 489–493.
Gur, RE, McGrath, C, Chan, RM, Schroeder, L, Turner, T, Turetsky, BI, Kohler, C, Alsop, D, Maldjian, J, Ragland, JD, Gur, RC (2002). An fMRI study of facial emotion processing in patients with schizophrenia. American Journal of Psychiatry 159, 1992–1999.
Gur, RE, Nimgaonkar, VL, Almasy, L, Calkins, ME, Ragland, JD, Pogue-Geile, MF, Kanes, S, Blangero, J, Gur, RC (2007). Neurocognitive endophenotypes in a multiplex multigenerational family study of schizophrenia. American Journal of Psychiatry 164, 813–819.
Habel, U, Klein, M, Shah, NJ, Toni, I, Zilles, K, Falkai, P, Schneider, F (2004). Genetic load on amygdala hypofunction during sadness in nonaffected brothers of schizophrenia patients. American Journal of Psychiatry 161, 1806–1813.
Hariri, AR, Bookheimer, SY, Mazziotta, JC (2000). Modulating emotional responses: effects of a neocortical network on the limbic system. Neuroreport 11, 43–48.
Hariri, AR, Mattay, VS, Tessitore, A, Fera, F, Weinberger, DR (2003). Neocortical modulation of the amygdala response to fearful stimuli. Biological Psychiatry 53, 494–501.
Hariri, AR, Tessitore, A, Mattay, VS, Fera, F, Weinberger, DR (2002). The amygdala response to emotional stimuli: a comparison of faces and scenes. Neuroimage 17, 317–323.
Heinz, A, Smolka, MN (2006). The effects of catechol O-methyltransferase genotype on brain activation elicited by affective stimuli and cognitive tasks. Reviews in the Neurosciences 17, 359–367.
Henry, JD, Green, MJ, de Lucia, A, Restuccia, C, McDonald, S, O'Donnell, M (2007). Emotion dysregulation in schizophrenia: reduced amplification of emotional expression is associated with emotional blunting. Schizophrenia Research 95, 197–204.
Ho, BC, Wassink, TH, O'Leary, DS, Sheffield, VC, Andreasen, NC (2005). Catechol-O-methyl transferase Val158Met gene polymorphism in schizophrenia: working memory, frontal lobe MRI morphology and frontal cerebral blood flow. Molecular Psychiatry 10, 229, 287–298.
Hollingshead, A, Redlich, F (1958). Social Class and Mental Illness. John Wiley: New York.
Howes, OD, Kambeitz, J, Kim, E, Stahl, D, Slifstein, M, Abi-Dargham, A, Kapur, S (2012). The nature of dopamine dysfunction in schizophrenia and what this means for treatment: meta-analysis of imaging studies. Archives of General Psychiatry. Published online 2 April 2012. doi:10.1001/archgenpsychiatry.2012.169.
Jensen, J, McIntosh, AR, Crawley, AP, Mikulis, DJ, Remington, G, Kapur, S (2003). Direct activation of the ventral striatum in anticipation of aversive stimuli. Neuron 40, 1251–1257.
Karayiorgou, M, Sobin, C, Blundell, ML, Galke, BL, Malinova, L, Goldberg, P, Ott, J, Gogos, JA (1999). Family-based association studies support a sexually dimorphic effect of COMT and MAOA on genetic susceptibility to obsessive-compulsive disorder. Biological Psychiatry 45, 1178–1189.
Karreman, M, Moghaddam, B (1996). The prefrontal cortex regulates the basal release of dopamine in the limbic striatum: an effect mediated by ventral tegmental area. Journal of Neurochemistry 66, 589–598.
Kay, SR, Fiszbein, A, Opler, LA (1987). The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin 13, 261–276.
Kremer, I, Pinto, M, Murad, I, Muhaheed, M, Bannoura, I, Muller, DJ, Schulze, TG, Reshef, A, Blanaru, M, Gathas, S, Goichman, R, Rietschel, M, Dobrusin, M, Bachner-Melman, R, Nemanov, L, Belmaker, RH, Maier, W, Ebstein, RP (2003). Family-based and case–control study of catechol-O-methyltransferase in schizophrenia among Palestinian Arabs. American Journal of Medical Genetics. Part B: Neuropsychiatric Genetics 119B, 35–39.
LaBar, KS, Gatenby, JC, Gore, JC, LeDoux, JE, Phelps, EA (1998). Human amygdala activation during conditioned fear acquisition and extinction: a mixed-trial fMRI study. Neuron 20, 937–945.
Lachman, HM, Papolos, DF, Saito, T, Yu, YM, Szumlanski, CL, Weinshilboum, RM (1996). Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6, 243–250.
Laruelle, M, Abi-Dargham, A, Gil, R, Kegeles, L, Innis, R (1999). Increased dopamine transmission in schizophrenia: relationship to illness phases. Biological Psychiatry 46, 56–72.
LeDoux, J (2003). The emotional brain, fear, and the amygdala. Cellular and Molecular Neurobiology 23, 727–738.
LeDoux, J (2007). The amygdala. Current Biology 17, R868–R874.
Li, H, Chan, RC, McAlonan, GM, Gong, QY (2010). Facial emotion processing in schizophrenia: a meta-analysis of functional neuroimaging data. Schizophrenia Bulletin 36, 1029–1039.
Mannisto, PT, Kaakkola, S (1999). Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacological Reviews 51, 593–628.
Matsumoto, M, Weickert, CS, Akil, M, Lipska, BK, Hyde, TM, Herman, MM, Kleinman, JE, Weinberger, DR (2003). Catechol O-methyltransferase mRNA expression in human and rat brain: evidence for a role in cortical neuronal function. Neuroscience 116, 127–137.
McGuffin, P, Riley, B, Plomin, R (2001). Genomics and behavior. Toward behavioral genomics. Science 291, 1232–1249.
McIntosh, AM, Baig, BJ, Hall, J, Job, D, Whalley, HC, Lymer, GK, Moorhead, TW, Owens, DG, Miller, P, Porteous, D, Lawrie, SM, Johnstone, EC (2007). Relationship of catechol-O-methyltransferase variants to brain structure and function in a population at high risk of psychosis. Biological Psychiatry 61, 1127–1134.
Menon, M, Jensen, J, Vitcu, I, Graff-Guerrero, A, Crawley, A, Smith, MA, Kapur, S (2007). Temporal difference modeling of the blood-oxygen level dependent response during aversive conditioning in humans: effects of dopaminergic modulation. Biological Psychiatry 62, 765–772.
Mier, D, Kirsch, P, Meyer-Lindenberg, A (2010). Neural substrates of pleiotropic action of genetic variation in COMT: a meta-analysis. Molecular Psychiatry 15, 918–927.
Miyake, N, Thompson, J, Skinbjerg, M, Abi-Dargham, A (2011). Presynaptic dopamine in schizophrenia. CNS Neuroscience and Therapeutics 17, 104–109.
Morris, JS, Frith, CD, Perrett, DI, Rowland, D, Young, AW, Calder, AJ, Dolan, RJ (1996). A differential neural response in the human amygdala to fearful and happy facial expressions. Nature 383, 812–815.
Moss, J, Bolam, JP (2008). A dopaminergic axon lattice in the striatum and its relationship with cortical and thalamic terminals. Journal of Neuroscience 28, 11221–11230.
Mueller, EM, Makeig, S, Stemmler, G, Hennig, J, Wacker, J (2011). Dopamine effects on human error processing depend on catechol-O-methyltransferase VAL158MET genotype. Journal of Neuroscience 31, 15818–15825.
Myin-Germeys, I, van Os, J (2007). Stress-reactivity in psychosis: evidence for an affective pathway to psychosis. Clinical Psychology Review 27, 409–424.
Myin-Germeys, I, van Os, J, Schwartz, JE, Stone, AA, Delespaul, PA (2001). Emotional reactivity to daily life stress in psychosis. Archives of General Psychiatry 58, 1137–1144.
Nixon, DC, Prust, MJ, Sambataro, F, Tan, HY, Mattay, VS, Weinberger, DR, Callicott, JH (2011). Interactive effects of DAOA (G72) and catechol-O-methyltransferase on neurophysiology in prefrontal cortex. Biological Psychiatry 69, 1006–1008.
Ochsner, KN, Gross, JJ (2005). The cognitive control of emotion. Trends in Cognitive Sciences 9, 242–249.
Oldfield, RC (1971). The assessment and analysis of handedness: The Edinburgh Inventory. Neuropsychologia 9, 97–113.
Ono, H, Shirakawa, O, Nushida, H, Ueno, Y, Maeda, K (2004). Association between catechol-O-methyltransferase functional polymorphism and male suicide completers. Neuropsychopharmacology 29, 1374–1377.
Phillips, ML (2003). Understanding the neurobiology of emotion perception: implications for psychiatry. British Journal of Psychiatry 182, 190–192.
Phillips, ML, Drevets, WC, Rauch, SL, Lane, R (2003 a). Neurobiology of emotion perception I: The neural basis of normal emotion perception. Biological Psychiatry 54, 504–514.
Phillips, ML, Drevets, WC, Rauch, SL, Lane, R (2003 b). Neurobiology of emotion perception II: Implications for major psychiatric disorders. Biological Psychiatry 54, 515–528.
Prata, DP, Mechelli, A, Fu, CH, Picchioni, M, Kane, F, Kalidindi, S, McDonald, C, Howes, O, Kravariti, E, Demjaha, A, Toulopoulou, T, Diforti, M, Murray, RM, Collier, DA, McGuire, PK (2009). Opposite effects of catechol-O-methyltransferase Val158Met on cortical function in healthy subjects and patients with schizophrenia. Biological Psychiatry 65, 473–480.
Rasetti, R, Mattay, VS, Wiedholz, LM, Kolachana, BS, Hariri, AR, Callicott, JH, Meyer-Lindenberg, A, Weinberger, DR (2009). Evidence that altered amygdala activity in schizophrenia is related to clinical state and not genetic risk. American Journal of Psychiatry 166, 216–225.
Reuter, M, Hennig, J (2005). Association of the functional catechol-O-methyltransferase VAL158MET polymorphism with the personality trait of extraversion. Neuroreport 16, 1135–1138.
Rujescu, D, Giegling, I, Gietl, A, Hartmann, AM, Moller, HJ (2003). A functional single nucleotide polymorphism (V158M) in the COMT gene is associated with aggressive personality traits. Biological Psychiatry 54, 34–39.
Rybakowski, JK, Borkowska, A, Czerski, PM, Hauser, J (2002). Eye movement disturbances in schizophrenia and a polymorphism of catechol-O-methyltransferase gene. Psychiatry Research 113, 49–57.
Salgado-Pineda, P, Fakra, E, Delaveau, P, Hariri, AR, Blin, O (2010). Differential patterns of initial and sustained responses in amygdala and cortical regions to emotional stimuli in schizophrenia patients and healthy participants. Journal of Psychiatry and Neuroscience 35, 41–48.
Sartori, G, Colombo, L, Vallar, G, Rusconi, ML, Pinarello, A (1997). T.I.B. Test di Intelligenza Breve per la valutazione del quoziente intellettivo attuale e pre-morboso [T.I.B. Brief intelligence test for assessing premorbid IQ]. Professione di Psicologo. Giornale dell'Ordine degli Psicologi 4, 1–24.
Sazci, A, Ergul, E, Kucukali, I, Kilic, G, Kaya, G, Kara, I (2004). Catechol-O-methyltransferase gene Val108/158Met polymorphism, and susceptibility to schizophrenia: association is more significant in women. Brain Research. Molecular Brain Research 132, 51–56.
Schlund, MW, Siegle, GJ, Ladouceur, CD, Silk, JS, Cataldo, MF, Forbes, EE, Dahl, RE, Ryan, ND (2010). Nothing to fear? Neural systems supporting avoidance behavior in healthy youths. Neuroimage 52, 710–719.
Schmack, K, Schlagenhauf, F, Sterzer, P, Wrase, J, Beck, A, Dembler, T, Kalus, P, Puls, I, Sander, T, Heinz, A, Gallinat, J (2008). Catechol-O-methyltransferase val158met genotype influences neural processing of reward anticipation. Neuroimage 42, 1631–1638.
Schwartz, CE, Wright, CI, Shin, LM, Kagan, J, Whalen, PJ, McMullin, KG, Rauch, SL (2003). Differential amygdalar response to novel versus newly familiar neutral faces: a functional MRI probe developed for studying inhibited temperament. Biological Psychiatry 53, 854–862.
Seamans, JK, Yang, CR (2004). The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Progress in Neurobiology 74, 1–58.
Shifman, S, Bronstein, M, Sternfeld, M, Pisante, A, Weizman, A, Reznik, I, Spivak, B, Grisaru, N, Karp, L, Schiffer, R, Kotler, M, Strous, RD, Swartz-Vanetik, M, Knobler, HY, Shinar, E, Yakir, B, Zak, NB, Darvasi, A (2004). COMT: a common susceptibility gene in bipolar disorder and schizophrenia. American Journal of Medical Genetics. Part B NeuroPsychiatric Genetics 128B, 61–64.
Slifstein, M, Kolachana, B, Simpson, EH, Tabares, P, Cheng, B, Duvall, M, Frankle, WG, Weinberger, DR, Laruelle, M, Abi-Dargham, A (2008). COMT genotype predicts cortical-limbic D1 receptor availability measured with [11C]NNC112 and PET. Molecular Psychiatry 13, 821–827.
Smolka, MN, Schumann, G, Wrase, J, Grusser, SM, Flor, H, Mann, K, Braus, DF, Goldman, D, Buchel, C, Heinz, A (2005). Catechol-O-methyltransferase Val158Met genotype affects processing of emotional stimuli in the amygdala and prefrontal cortex. Journal of Neuroscience 25, 836–842.
Stein, MB, Fallin, MD, Schork, NJ, Gelernter, J (2005). COMT polymorphisms and anxiety-related personality traits. Neuropsychopharmacology 30, 2092–2102.
Suslow, T, Ohrmann, P, Bauer, J, Rauch, AV, Schwindt, W, Arolt, V, Heindel, W, Kugel, H (2006). Amygdala activation during masked presentation of emotional faces predicts conscious detection of threat-related faces. Brain and Cognition 61, 243–248.
Tan, HY, Chen, Q, Goldberg, TE, Mattay, VS, Meyer-Lindenberg, A, Weinberger, DR, Callicott, JH (2007). Catechol-O-methyltransferase Val158Met modulation of prefrontal–parietal–striatal brain systems during arithmetic and temporal transformations in working memory. Journal of Neuroscience 27, 13393–13401.
Tessitore, A, Hariri, AR, Fera, F, Smith, WG, Das, S, Weinberger, DR, Mattay, VS (2005). Functional changes in the activity of brain regions underlying emotion processing in the elderly. Psychiatry Research 139, 9–18.
Thermenos, HW, Seidman, LJ, Breiter, H, Goldstein, JM, Goodman, JM, Poldrack, R, Faraone, SV, Tsuang, MT (2004). Functional magnetic resonance imaging during auditory verbal working memory in nonpsychotic relatives of persons with schizophrenia: a pilot study. Biological Psychiatry 55, 490–500.
Toomey, R, Seidman, LJ, Lyons, MJ, Faraone, SV, Tsuang, MT (1999). Poor perception of nonverbal social–emotional cues in relatives of schizophrenic patients. Schizophrenia Research 40, 121–130.
Tottenham, N, Tanaka, JW, Leon, AC, McCarry, T, Nurse, M, Hare, TA, Marcus, DJ, Westerlund, A, Casey, BJ, Nelson, C (2009). The NimStim set of facial expressions: judgments from untrained research participants. Psychiatry Research 168, 242–249.
Tsai, SJ, Hong, CJ, Yu, YW, Chen, TJ (2004). Association study of catechol-O-methyltransferase gene and dopamine D 4receptor gene polymorphisms and personality traits in healthy young Chinese females. Neuropsychobiology 50, 153–156.
Tunbridge, EM, Harrison, PJ, Weinberger, DR (2006). Catechol-o-methyltransferase, cognition, and psychosis: Val158Met and beyond. Biological Psychiatry 60, 141–151.
van Buuren, M, Vink, M, Rapcencu, AE, Kahn, RS (2011). Exaggerated brain activation during emotion processing in unaffected siblings of patients with schizophrenia. Biological Psychiatry 70, 81–87.
Volavka, J, Kennedy, JL, Ni, X, Czobor, P, Nolan, K, Sheitman, B, Lindenmayer, JP, Citrome, L, McEvoy, J, Lieberman, JA (2004). COMT158 polymorphism and hostility. American Journal of Medical Genetics. Part B NeuroPsychiatric Genetics 127B, 28–29.
Weinberger, DR (1987). Implications of normal brain development for the pathogenesis of schizophrenia. Archives of General Psychiatry 44, 660–669.
Weinberger, DR, Egan, MF, Bertolino, A, Callicott, JH, Mattay, VS, Lipska, BK, Berman, KF, Goldberg, TE (2001). Prefrontal neurons and the genetics of schizophrenia. Biological Psychiatry 50, 825–844.
Weinshilboum, RM, Otterness, DM, Szumlanski, CL (1999). Methylation pharmacogenetics: catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase. Annual Review of Pharmacology and Toxicology 39, 19–52.
Williams, LM, Das, P, Harris, AW, Liddell, BB, Brammer, MJ, Olivieri, G, Skerrett, D, Phillips, ML, David, AS, Peduto, A, Gordon, E (2004). Dysregulation of arousal and amygdala–prefrontal systems in paranoid schizophrenia. American Journal of Psychiatry 161, 480–489.
Williams, LM, Das, P, Liddell, BJ, Kemp, AH, Rennie, CJ, Gordon, E (2006). Mode of functional connectivity in amygdala pathways dissociates level of awareness for signals of fear. Journal of Neuroscience 26, 9264–9271.
Woo, JM, Yoon, KS, Yu, BH (2002). Catechol O-methyltransferase genetic polymorphism in panic disorder. American Journal of Psychiatry 159, 1785–1787.
Woodward, ND, Tibbo, P, Purdon, SE (2007). An fMRI investigation of procedural learning in unaffected siblings of individuals with schizophrenia. Schizophrenia Research 94, 306–316.
Wright, CI, Martis, B, Schwartz, CE, Shin, LM, Fischer, HH, McMullin, K, Rauch, SL (2003). Novelty responses and differential effects of order in the amygdala, substantia innominata, and inferior temporal cortex. Neuroimage 18, 660–669.
Yang, TT, Menon, V, Eliez, S, Blasey, C, White, CD, Reid, AJ, Gotlib, IH, Reiss, AL (2002). Amygdalar activation associated with positive and negative facial expressions. Neuroreport 13, 1737–1741.
Zandbelt, BB, van Buuren, M, Kahn, RS, Vink, M (2011). Reduced proactive inhibition in schizophrenia is related to corticostriatal dysfunction and poor working memory. Biological Psychiatry 70, 1151–1158.